For the BeOne digital health team
The site you just explored is a Genflare demonstration: a modern, journey-first rebuild that makes CLL Navigator far easier to find your way through, read, and act on. Every page, word, link, and approval code from your live site is preserved, so the experience moves forward while the approved content stays exactly as it is.
Why the rebuild matters
Your content was strong; its structure buried it. We rebuilt CLL Navigator around the person using it and brought the whole experience up to a modern standard, without touching a word of approved copy.
Journey-first wayfinding routes someone by their moment, newly diagnosed, watch-and-wait, in treatment, or caregiving, instead of guessing which dropdown holds the answer. Less hunting, less overwhelm at a hard time.
A refreshed visual system built from BeOne's own brand, consistent page templates, mobile-first layouts, on-page jump-navs, read-time labels, and accessible text sizing, so content is easy to scan and trust on any device.
The community sign-up and support resources are surfaced consistently across the site, so the step from learning about CLL to getting help is always one tap away.
What changed, and what it means for review
Most of the work needs no review at all. The only items a reviewer should look at are in the third column, and each reuses content you've already approved.
Carried over verbatim from your live site.
The craft of the rebuild. Structure and presentation only, so none of it needs review.
A short list, each clearable on sight because the content already exists.
How we'd take it to your team
For a live build, we produce the formal review package to your team's template: annotated claims mapped to references, a complete change log, and a submission determination, so your reviewers spend their time only on what truly needs judgment.
This overview is a working model, not legal advice. The "unbranded is lower-review" approach rests on FDA practice and current guidance; final classification of any asset belongs to your MLR/PRC team and counsel.
Explore the redesigned site →